| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37f4922dfb7777b019e504b885211b8e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2daf6d7a06768f0db6ce61cf2f44ece2 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G69-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G69-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0207
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-59
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08L75-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K4-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08L77-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08L75-02 |
| filingDate |
2014-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ff80f211e1cb6b7ec95cc38711aec19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7156259778cdc7077874525e5981124d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3dfefc2016a572c73e9de8c3c78bd1fd |
| publicationDate |
2015-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2015024955-A1 |
| titleOfInvention |
Peptide-oligourea chimeric compounds and methods of their use |
| abstract |
The present description provides compositions and methods for producing therapeutic oligomeric compounds. In another aspect the description provides methods for administering the oligomeric compounds for the treatment and prevention of disease in a mammal. In particular, the invention relates to medicaments comprising various novel oligomeric compounds and pharmaceutically acceptable salts thereof. The compounds of the invention may optionally be administered with at least one of a pharmaceutically acceptable excipient, additional pharmacologically active agent or a combination thereof. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016207726-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017037150-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10233213-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10414722-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017037142-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11267861-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017182873-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020148317-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3138851-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10398750-B2 |
| priorityDate |
2013-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |